Ethyl 3-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[c]pyridine-6-carboxylate

Catalog No.: 
ACEXZA362
CAS No.: 
1026417-03-7
Molecular Formula: 
C12H13NO3
Molecular Weight: 
219.24
Ethyl 3-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[c]pyridine-6-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$235.00InquiryInquiry
250mg95%$505.00InquiryInquiry
1g95%$1275.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 3-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[c]pyridine-6-carboxylate
IUPAC Nameethyl 3-methyl-7-oxo-6,7-dihydro-5H-cyclopenta[c]pyridine-6-carboxylate
MDL No.MFCD27922158
Molecular FormulaC12H13NO3
Molecular Weight219.24
SMILESO=C(C(C1=O)CC2=C1C=NC(C)=C2)OCC
InChI KeyZFKCLYRGGDRTAW-UHFFFAOYSA-N
SynonymETHYL 3-METHYL-7-OXO-6,7-DIHYDRO-5H-CYCLOPENTA[C]PYRIDINE-6-CARBOXYLATE;5H-Cyclopenta[c]pyridine-6-carboxylic acid, 6,7-dihydro-3-methyl-7-oxo-, ethyl ester
CAS No.1026417-03-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACEXZA362 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEXZA362 route product structure diagram
    ACEXZA3621026417-03-7
Inquiry

2. ACEXZA362 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEXZA362 route product structure diagram
    ACEXZA3621026417-03-7
Inquiry

3. ACEXZA362 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEXZA362 route product structure diagram
    ACEXZA3621026417-03-7
Inquiry

Comments (0)